About Rameda
Rameda is a company based in Giza (Egypt) founded in 1994. Rameda operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Shaanxi Micot Technology, among others.
- Headquarter Giza, Egypt
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Tenth Of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
-
Annual Revenue
$2.77 B44.03as on Dec 31, 2024
-
Net Profit
$363.84 M62.79as on Dec 31, 2024
-
EBITDA
$766.07 M53.16as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Rameda
Rameda is a publicly listed company on the EGX with ticker symbol RMDA in Egypt, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Rameda
Unlock access to complete
Funding Insights of Rameda
Investors in Rameda
Rameda has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Public Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manages investments in energy, real estate, and technology to support national development.
|
Locked | Locked | Locked |
Investor details for Rameda
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rameda
Investment portfolio details for Rameda
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rameda
Detailed financials for Rameda
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rameda Comparisons
Peer comparison for Rameda
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rameda
Rameda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Shaanxi Micot Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| Locked | Locked | Locked |
Drug R&D services for cardiovascular and metabolic diseases are provided.
|
Detailed competitors of Rameda
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rameda
Complete news archive for Rameda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rameda
Rameda was founded in 1994 and raised its 1st funding round 28 years after it was founded.
Rameda is headquartered in Giza, Egypt.
Founded in 1994, Rameda operates as a developer and manufacturer in the pharmaceutical sector, focusing on generic drugs, nutraceuticals, food supplements, and veterinary products. Based in Giza, Egypt, the company handles production processes for these categories, serving markets through standard formulations and quality controls typical of the industry. Operations emphasize regulatory compliance and supply chain management for domestic and potential export needs.
Rameda's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
Yes, Rameda is publicly traded on EGX under the ticker symbol RMDA.
Rameda has 1 investor. Key investors include Public Investment Fund.
The ticker symbol of Rameda is RMDA on EGX.